CLPTClearPoint Neuro, Inc.
What is the market doing?
The market is leaning against it: in a downtrend (−30% vs 200-day) and a crowded short (+16% of shares).
In a downtrend, below its 50- and 200-day averages. Oversold (RSI 20). Price is −30% vs its 200-day average.
A crowded short, settled Sep 30, 2026, about a week of normal trading to cover.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How CLPT is trading
ClearPoint Neuro, Inc. is −62% over the past year while the S&P 500 is +16%: 78 points behind the market.
1-year return · S&P 500 +16%
- vs 200-day average
- −30%
vs 200-day average · a clear downtrend
- RSI (14)
- 20
RSI (14) · oversold, sold harder than it has been bought
- Below its 52-week high
- 66%
Below its 52-week high
Details›
- Last close2026-10-23
- $9.13
- 1 monthS&P 500 −0.94%
- −38%
- 1 yearS&P 500 +16%
- −62%
- 5 yearsS&P 500 +86%
- −49%
- vs 50-day average$13.04
- −30%
- 52-week high
- $26.98
- 52-week low
- $8.66
- Annualised volatility
- 91%
- Insider selling, net, 6 monthsForms 3/4/5 to 2026-10-22
- $251K
| Year | Return |
|---|---|
| 2026 (year to date) | −33% |
| 2025 | −11% |
| 2024 | +127% |
| 2023 | −20% |
| 2022 | −25% |
| 2021 | −29% |
| 2020 | +231% |
| 2019 | +206% |
| 2018 | −43% |
| 2017 | −19% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 10 | 7 of 10 | +11% |
| Feb | 10 | 3 of 10 | −2.1% |
| Mar | 10 | 5 of 10 | +3.3% |
| Apr | 10 | 5 of 10 | +3.2% |
| May | 10 | 4 of 10 | −7.1% |
| Jun | 10 | 6 of 10 | +7.0% |
| Jul | 11 | 5 of 11 | +0.68% |
| Aug | 11 | 3 of 11 | −0.79% |
| Sep | 11 | 5 of 11 | +13% |
| Oct | 11 | 5 of 11 | −1.3% |
| Nov | 10 | 4 of 10 | −5.1% |
| Dec | 10 | 5 of 10 | +11% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Where the price stands
Its trend against the 50-day and 200-day averages, and the levels it keeps coming back to.
What it has returned
With dividends, year by year, month by month, and by calendar month on average.